Gabelli Healthcare holder Saba buys 500 shares

Rhea-AI Filing Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that major shareholder Saba Capital Management, L.P., a ten percent owner, purchased 500 shares of common stock on September 3, 2026, at $10.08 per share in an open-market or private transaction, held indirectly. Following this trade, Saba Capital’s reported indirect holdings rose to 2,155,633 shares. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Net Buyer: 500 shares

Net Buy 1 txn

Insider Saba Capital Management, L.P.

Role 10% Owner

Bought 500 shs ($5K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	500	$10.08	$5K

Holdings After Transaction: Common Stock — 2,155,633 shares (Indirect, -)

Key Figures

Shares purchased: 500 shares Purchase price per share: $10.08 per share Total shares held after transaction: 2,155,633 shares

3 metrics

Shares purchased 500 shares Common stock bought on September 3, 2026

Purchase price per share $10.08 per share Price paid for GRX common stock on September 3, 2026

Total shares held after transaction 2,155,633 shares Indirect GRX common stock holdings by Saba Capital Management after the purchase

Key Terms

ten percent owner, indirect, open market or private transaction

3 terms

ten percent owner regulatory

"Saba Capital Management, L.P. is identified as a ten percent owner"

indirect regulatory

"The ownership type for this position is reported as indirect"

open market or private transaction financial

"The purchase is described as in an open market or private transaction"

FAQ

What insider transaction did GRX disclose from Saba Capital Management?

GRX disclosed that Saba Capital Management, L.P., a ten percent owner, purchased 500 shares of common stock on September 3, 2026 in an open-market or private transaction at a reported price of $10.08 per share, held indirectly.

How many GRX shares does Saba Capital Management hold after this Form 4 transaction?

After the reported transaction, Saba Capital Management’s indirect holdings in GRX common stock total 2,155,633 shares, as stated in the filing’s post-transaction ownership figure.

What price did Saba Capital Management pay per GRX share in this Form 4 filing?

Saba Capital Management paid a reported $10.08 per share for 500 GRX common shares in the September 3, 2026 transaction, characterized as a purchase in an open-market or private transaction.

Is Saba Capital’s GRX transaction under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote indicating a trading plan, so the September 3, 2026 purchase is not reported as being made under a Rule 10b5-1 plan.

Is Saba Capital Management a significant shareholder of GRX?

Yes. The Form 4 identifies Saba Capital Management, L.P. as a ten percent owner of Gabelli Healthcare & WellnessRx Trust, indicating a significant ownership position in the company’s common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 10:01 AM Accepted by SEC EDGAR 09/08/2026 - 10:00 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saba Capital Management, L.P.

(Last) (First) (Middle)

405 LEXINGTON AVENUE

58TH FLOOR

(Street)

NEW YORK NEW YORK 10174

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/03/2026		P		500	A	$10.08	2,155,633	I	-

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Saba Capital Management, L.P. By: Zachary Gindes	09/08/2026
	Boaz Weinstein	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)